Cell and gene therapies: Stagnation or maturation? Despite questions around stagnation, experts argue that cell and gene therapies are evolving rapidly –driven by innovation in manufacturing, decentralisation, and targeted delivery. Nicole Raleigh gat...

#Cellandgenetherapies #CGTs #CARTs #FDA #cellandgeneandtissuetherapies #CARTcelltherapies #AAV #autologousCARTtherapies #CD19 #BCMA #REMS #celltherapytechnologies #AnthonyNolan #CARTworkflow #Vertex #bluebirdbio #eXmoorPharma #CGTindustry #personalisedtreatment
pharmaphorum.com/deep-dive/ce...